Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 120 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/19
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 08/12/18
End: 06/12/20
Due: 06/12/21
Phase: N/A
Priority: Normal
Start: 10/10/23
End: 10/10/24
Due: 10/10/25
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 08/18/20
End: 07/31/23
Due: 07/31/24
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 12/01/21
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 10/01/22
Due: 10/01/23
Phase: N/A
Priority: Normal
Start: 09/08/20
End: 05/30/21
Due: 05/30/22
Phase: N/A
Priority: Normal
Start: 06/03/24
End: 06/30/25
Due: 06/30/26
Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis
Phase: N/A
Priority: Normal
Start: 03/27/24
End: 05/01/26
Due: 05/01/27
Phase: N/A
Priority: Normal
Start: 11/25/19
End: 11/24/20
Due: 11/24/21
Phase: N/A
Priority: Normal
Start: 02/20/23
End: 02/19/29
Due: 02/19/30
Phase: N/A
Priority: Normal
Start: 08/10/17
End: 01/10/18
Due: 01/10/19
Phase: N/A
Priority: Normal
Start: 10/01/25
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 02/01/22
End: 12/30/22
Due: 12/30/23
Phase: N/A
Priority: Normal
Start: 11/01/16
End: 02/01/18
Due: 02/01/19
Phase: N/A
Priority: Normal
Start: 06/06/20
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 08/10/21
End: 08/09/22
Due: 08/09/23
Phase: N/A
Priority: Normal
Start: 11/12/20
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 12/30/25
Due: 12/30/26
Phase: N/A
Priority: Normal
Start: 02/21/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 12/30/23
End: 04/30/24
Due: 04/30/25
Phase: N/A
Priority: Normal
Start: 12/04/19
End: 12/31/25
Due: 12/31/26